Search Results 601-610 of 17092 for monoclonal antibody
... monoclonal antibody reversed the therapeutic effect of IVIG. Protection was associated with the ability of IVIG administration to induce surface expression ...
About this study. The study is being done to identify how many Healthcare workers develop antibodies against the SARS-CoV 2 virus over a 6 month period ...
Monoclonal antibodies, such as cixutumumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...
The development of trastuzumab in the early 2000s as an antibody-based targeted therapeutic for HER2+ breast cancer heralded a new era of precision medicine in ...
Contact the Antibody Hybridoma Core at Mayo Clinic's campus in Rochester, Minnesota, to request services or schedule a consultation.
The purpose of this study is to determine the efficacy of pembrolizumab in patients with advanced sarcomas. Participation eligibility. Participant eligibility ...
Sophisticated laboratory testing solved a medical riddle and finally got Jori Pearson back on his feet, doing what he loves. Jori Pearson was a 39-year-old ...
... monoclonal antibody that targets CD38, a protein found on the surface of myeloma cells, significantly reduces the risk of progression to active multiple ...
This is a Phase I/II study designed to evaluate if experimental anti-TIGIT/anti-PD-1 bispecific antibody rilvegostomig (AZD2936) is safe, tolerable and ...
Monoclonal antibodies, such as atezolizumab, may interfere with the ability of tumor cells to grow and spread. Cobimetinib may stop the growth of tumor ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift today can have 5X the impact on AI research and technology. But hurry — the match challenge ends 9/19.